Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for CINV Prevention
NCT04181346Phase 2Unknown
- Sponsor
- Centro Universitário Faculdade de Medicina do ABC
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in chemotherapy-induced nausea and vomiting (CINV), sponsored by Centro Universitário Faculdade de Medicina do ABC. Status: unknown.
02
Drugs
pregabalin
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04181346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181346.